GlassScriptPhysician profile
Robert Michael Aszkler
NPI 1679894794
$6,818.40
in general payments reported to CMS, 2019-2025
9 companies · $1,640 in 2025
The $1,640 reported for 2025 was more than what 94% of Orthodontics and Dentofacial Orthopedics providers received nationally (typical 2025 total: $146).
See the full distribution for Orthodontics and Dentofacial Orthopedics
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $821 · 2020: $468 · 2021: $437 · 2022: $2,377 · 2023: $821 · 2024: $255 · 2025: $1,640.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,982 · Travel and Lodging: $489 · Education: $175 · Gift: $69.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,981.89 |
| Travel and Lodging | $489.20 |
| Education | $175.00 |
| Gift | $69.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $3,169.93 | 2019-2025 | Invisalign, Itero Element 5d Plus Lite, Itero Element 5d Plus |
| Lightforce Orthodontics, INC. | $2,711.63 | 2022-2025 | |
| American Orthodontics Corporation | $596.03 | 2021-2025 | Radiance, Empower-Ceramic, LP and Ifit Tubes |
| Dental Monitoring Sas | $159.96 | 2025 | |
| Ortho Organizers, INC. | $93.64 | 2019 | |
| Envista Holdings Corporation | $37.75 | 2024-2025 | Ortho Solo, Spark |
| Ormco Corporation | $21.97 | 2019 | |
| Colgate Oral Pharmaceuticals, INC. | $14.13 | 2025 | |
| Dentsply Sirona Orthodontics INC | $13.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Aszkler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.